Navigation Links
Educating the Market: Creating Value Through Support of Continuing Medical Education

CHAPEL HILL, N.C., Feb. 24 /PRNewswire/ -- Though the American Medical Association and others have called for greater transparency surrounding pharmaceutical industry funding of CME and though some big pharma companies have recently moved to better define funding protocol (one even eliminating funding for CME by third-party vendors), 75 - 100 percent of CME programming at most medical associations and teaching hospitals is funded by the bio-pharma industry. As one interviewed VP put it: "No one else will or can support [CME]."

"Educating the Market: Creating Value Through Support of Continuing Medical Education," a just-published benchmarking report from Best Practices, LLC, explores the changing CME landscape in Europe and North America. The research contained in this report examines not only current CME debates in structuring, standardization, and accreditation, but also shows how new delivery methods like E-CME are transforming the face of Continuing Medical Education around the world.

Now available at, this new 2009 study's sample findings include:

  • Seventy-four percent of study participants report decreased funding in the past two years and 100% of partners forecast a decrease in funding going forward.
  • A majority of benchmark companies (68%) utilize a decentralized function for CME management or oversight, with 36% involving independent oversight per region and 32% local oversight per country. Although only 29% of benchmark companies employ a centralized structure, those that do reported significant impact through increased leverage of budgets and headcounts.
  • In Europe, 61% of CME is functionally managed by Marketing, as compared to just 26% in North America.
  • Face-to-Face delivery forms predominate in both North America (50.4%) and
  • Europe (65.4%). Enduring Materials deliver just under 20% of CME in both continents.
  • E-CME delivery is more than twice as prevalent in North America (23.9%) than Europe (10.9%).

The leading practices, managerial insights and benchmark metrics in "Educating the Market: Creating Value Through Support of Continuing Medical Education" are drawn from interviews and benchmarking surveys with 30 CME leaders from 26 pharmaceutical and biotechnology companies in both Europe and North America. The research also contains quantitative data and insights from seven third-party CME vendors and eight medical associations and teaching hospitals.

A complimentary summary of "Educating the Market: Creating Value Through Support of Continued Medical Education" is available at For more information, contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 18 years; our clients include 48 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Patient Safety Authority Launches New Website and Design With New Tagline Analyzing, Educating and Collaborating for Patient Safety
2. Educating the Market: Creating Value through Support of Continuing Medical Education
3. AUDIO from Medialink and the National Alliance for Hispanic Health: Educating the Hispanic Community About ADHD
4. Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets
5. Frost & Sullivan to Host Analyst Briefing on the European Orphan Diseases Market: Niche-Busters - An Attractive Future?
6. HealthCentral Acquires Wellsphere Creating the Largest Organically Driven Online Health and Wellness Communities
7. Health IT Can Play an Essential Role in Stimulating the Economy and Creating Jobs
8. Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities
9. Leaders at Henry Ford Health System and Memorial Hermann Healthcare System Awarded for Commitment to Creating Safer, More Transparent Environments for Patients
10. Creating Brand Advocates by Delivering the Superior Total Customer Experience
11. Engineer creating more sensitive, safer landmine detectors
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: